GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+2.72%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$499M
AUM Growth
+$499M
(-1.3%)
Cap. Flow
-$11.9M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
53.36%
Holding
52
New
8
Increased
14
Reduced
11
Closed
14
Top Buys
| 1 |
Zura Bio
ZURA
|
$27M |
| 2 |
Sarepta Therapeutics
SRPT
|
$14.2M |
| 3 |
Alkermes
ALKS
|
$12.9M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
$11.1M |
| 5 |
Aclaris Therapeutics
ACRS
|
$7.78M |
Top Sells
| 1 |
Jazz Pharmaceuticals
JAZZ
|
$21.9M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$16.9M |
| 3 |
Travere Therapeutics
TVTX
|
$14.5M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$12.6M |
| 5 |
Xenon Pharmaceuticals
XENE
|
$11.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
1
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $34.6M | 6.77% | 3,363,688 -377,073 | -10% | -$3.88M |
|
2
Ultragenyx Pharmaceutical
RARE
$2.89B
| $31.2M | 6.12% | 677,426 | – | – |
|
3
Vaxcyte
PCVX
$4B
| $29.4M | 5.76% | 589,211 -70,000 | -11% | -$3.5M |
|
4
Pliant Therapeutics
PLRX
$101M
| $28.1M | 5.5% | 1,550,184 +338,088 | +28% | +$6.13M |
|
5
RAPT Therapeutics
RAPT
$188M
| $27.4M | 5.36% | 1,465,151 +110,000 | +8% | +$2.06M |
|
|
PNT
6
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $27.2M | 5.32% | 3,000,000 -383,029 | -11% | -$3.47M |
|
|
7
Zura Bio
ZURA
$133M
| $27M | 5.29% | +3,295,000 | New | +$27M |
|
8
Amylyx Pharmaceuticals
AMLX
$836M
| $20.9M | 4.09% | 968,795 +185,000 | +24% | +$3.99M |
|
|
9
Xenon Pharmaceuticals
XENE
$2.98B
| $20.4M | 3.99% | 530,000 -288,505 | -35% | -$11.1M |
|
|
10
Aclaris Therapeutics
ACRS
$209M
| $20.1M | 3.94% | 1,941,581 +750,000 | +63% | +$7.78M |
|
11
Cytokinetics
CYTK
$4.23B
| $19.6M | 3.83% | 600,000 +100,000 | +20% | +$3.26M |
|
12
AnaptysBio
ANAB
$569M
| $18.2M | 3.56% | 894,333 +90,000 | +11% | +$1.83M |
|
13
Immunocore
IMCR
$1.62B
| $17.8M | 3.49% | 297,082 +41,715 | +16% | +$2.5M |
|
14
Evolus
EOLS
$494M
| $17.7M | 3.46% | 2,434,048 +241,232 | +11% | +$1.75M |
|
|
JBIO
15
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $16M | 3.13% | 932,158 +176,538 | +23% | +$3.03M |
|
|
16
Sarepta Therapeutics
SRPT
$1.78B
| $14.2M | 2.77% | +123,600 | New | +$14.2M |
|
|
17
Alkermes
ALKS
$4.78B
| $12.9M | 2.52% | +411,453 | New | +$12.9M |
|
|
18
Rhythm Pharmaceuticals
RYTM
$6.85B
| $12.7M | 2.49% | 772,000 +674,456 | +691% | +$11.1M |
|
|
OPTN
19
DELISTED
OptiNose
OPTN
| $10.9M | 2.13% | 8,839,939 +945,203 | +12% | +$1.16M |
|
20
Viking Therapeutics
VKTX
$3.04B
| $9.7M | 1.9% | 598,550 -401,450 | -40% | -$6.51M |
|
21
Mineralys Therapeutics
MLYS
$1.03B
| $9.31M | 1.82% | 546,059 -74,267 | -12% | -$1.27M |
|
22
Amicus Therapeutics
FOLD
$2.34B
| $8.81M | 1.72% | 701,392 +321,392 | +85% | +$4.04M |
|
|
GRCL
23
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $8.64M | 1.69% | 2,268,057 -885,149 | -28% | -$3.37M |
|
|
OKUR
24
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $7.11M | 1.39% | 1,083,317 +962,453 | +796% | +$6.31M |
|
|
ICPT
25
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $6.65M | 1.3% | +601,322 | New | +$6.65M |
|